99 related articles for article (PubMed ID: 6939646)
1. Lethal toxicity and myelotoxicity to mice of the combination of 6-thioguanine and 3-[(4-amine-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride.
Fujimoto S; Ogawa M
Gan; 1980 Oct; 71(5):667-73. PubMed ID: 6939646
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic synergism elicited by the combination of 6-thioguanine and 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride: synergistic cytocidal activity against L1210 cells in vitro.
Fujimoto S; Ogawa M
Gan; 1980 Oct; 71(5):659-66. PubMed ID: 6939645
[TBL] [Abstract][Full Text] [Related]
3. Potentiation of therapeutic effects of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride by 6-thioguanine in mouse tumor systems: comparison with other antimetabolites.
Fujimoto S; Ogawa M; Hoshino A
Gan; 1980 Feb; 71(1):60-72. PubMed ID: 6929770
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity and toxicity of ACNU, 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitroso urea hydrochloride, comparing two divided doses and a single dose.
Fujimoto S; Wang Y; Ogawa M
Cancer Chemother Pharmacol; 1984; 12(3):173-8. PubMed ID: 6584235
[TBL] [Abstract][Full Text] [Related]
5. Hypothetical mechanism of therapeutic synergism induced by the combination of 6-thioguanine and 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride.
Fujimoto S; Ogawa M; Sakurai Y
Cancer Res; 1982 Oct; 42(10):4079-85. PubMed ID: 6955008
[No Abstract] [Full Text] [Related]
6. Combination chemotherapy of 6-thioguanine with various antitumor agents against murine leukemia L-1210.
Fujimoto S; Inagaki J; Horikoshi N; Hoshino A
Gan; 1977 Oct; 68(5):543-52. PubMed ID: 201534
[TBL] [Abstract][Full Text] [Related]
7. Combination chemotherapy with 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride and bleomycin in meningeal carcinomatosis in rats.
Shimizu K; Ushio Y; Hayakawa T; Mogami H
Cancer Res; 1980 Apr; 40(4):1341-3. PubMed ID: 6153573
[TBL] [Abstract][Full Text] [Related]
8. Chemical structure of carbamoylating groups and their relationship to bone marrow toxicity and antiglioma activity of bifunctionally alkylating and carbamoylating nitrosoureas.
Ali-Osman F; Giblin J; Berger M; Murphy MJ; Rosenblum ML
Cancer Res; 1985 Sep; 45(9):4185-91. PubMed ID: 2411398
[TBL] [Abstract][Full Text] [Related]
9. Toxicological study on a new nitrosourea derivative, 1-(2-chloroethyl)-3-isobutyl-3-(beta-maltosyl)-1-nitrosourea.
Fujimoto S; Ogawa M
Jpn J Cancer Res; 1985 Jul; 76(7):651-6. PubMed ID: 3928562
[TBL] [Abstract][Full Text] [Related]
10. Central nervous system toxicity and cerebrospinal fluid pharmacokinetics of intraventricular 3-[(4-amino-2-methyl-5-pyrimidinyl)ethyl]-1-(2-chloroethyl)-1-nitro soureas and other nitrosoureas in beagles.
Levin VA; Byrd D; Campbell J; Giannini DD; Borcich JK; Davis RL
Cancer Res; 1985 Aug; 45(8):3803-9. PubMed ID: 3860287
[TBL] [Abstract][Full Text] [Related]
11. Potentiation by squalene of antitumor effect of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-nitros ourea in a murine tumor system.
Yamaguchi T; Nakagawa M; Hidaka K; Yoshida T; Sasaki T; Akiyama S; Kuwano M
Jpn J Cancer Res; 1985 Oct; 76(10):1021-6. PubMed ID: 3935620
[TBL] [Abstract][Full Text] [Related]
12. [Effects of phenobarbital on the metabolism of ACNU in vivo].
Nagashima T; Matsutani M; Kohono T
No To Shinkei; 1983 Jul; 35(7):677-82. PubMed ID: 6578801
[TBL] [Abstract][Full Text] [Related]
13. Distribution, excretion, and metabolism of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea (ACNU) in rats and mice after iv administration.
Tanaka M; Nishigaki T; Nakajima E; Totsuka S; Nakamura K
Cancer Treat Rep; 1980; 64(4-5):575-80. PubMed ID: 6933003
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity and toxicity of methyl 6-[3-(2-chloroethyl)- 3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside in experimental animals.
Fujimoto S; Tashiro T; Ogawa M
Gan; 1984 Oct; 75(10):937-46. PubMed ID: 6510639
[TBL] [Abstract][Full Text] [Related]
15. Comparison of antitumor activities of nitrosourea derivatives against mammary breast carcinoma (MX-1) in nude mice.
Inoue K; Fujimoto S; Ogawa M
Gan; 1980 Oct; 71(5):686-91. PubMed ID: 7227717
[TBL] [Abstract][Full Text] [Related]
16. [Intensive 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride (ACNU) and cryopreserved autologous bone marrow transplantation].
Sampi K; Kumai R; Yanagawa S; Hattori M
Gan To Kagaku Ryoho; 1988 Aug; 15(8):2339-41. PubMed ID: 3044278
[No Abstract] [Full Text] [Related]
17. [ACNU delivery to malignant tumor tissue and serum--route of administration and combined use of phenobarbital].
Muraoka K
No To Shinkei; 1983 Dec; 35(12):1199-206. PubMed ID: 6584117
[TBL] [Abstract][Full Text] [Related]
18. [Pancreatic and biliary excretion of 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride (ACNU) in man].
Matsuno S; Kakizaki K; Sasaki K; Sato T
Gan To Kagaku Ryoho; 1983 Jun; 10(6):1486-90. PubMed ID: 6575728
[TBL] [Abstract][Full Text] [Related]
19. Continuation of phase II study of 1-(4-amino-2-methylpyrimidine-5-yl)-methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride (ACNU).
Saito T
Recent Results Cancer Res; 1980; 70():91-106. PubMed ID: 6986644
[No Abstract] [Full Text] [Related]
20. Comparative studies on the antitumor activity and the bone marrow toxicity of 1-(beta-D-glucopyranosyl)-3-(2-chloroethyl)-3-nitrosourea and 2-(3-(2-chloroethyl)-3-nitrosoureido)-D-glucopyranose.
Aoshima M; Sakurai Y
Gan; 1977 Apr; 68(2):247-50. PubMed ID: 892299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]